- Home
- CTO vs BVS Comparison
CTO vs BVS Comparison
Compare CTO & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTO | BVS |
|---|---|---|
| Founded | 1902 | 2011 |
| Country | United States | United States |
| Employees | 42 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 695.9M | 716.8M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | CTO | BVS |
|---|---|---|
| Price | $21.55 | $11.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $22.50 | $14.00 |
| AVG Volume (30 Days) | 397.3K | ★ 582.9K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 7.44% | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | $7.63 | $7.52 |
| Revenue Next Year | $2.76 | $7.06 |
| P/E Ratio | ★ N/A | $262.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.07 | $5.81 |
| 52 Week High | $22.01 | $11.25 |
Technical Indicators
Market Signals| Indicator | CTO | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 59.44 | 76.01 |
| Support Level | $19.76 | $8.12 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.39 | 0.49 |
| MACD | 0.04 | 0.28 |
| Stochastic Oscillator | 65.81 | 95.38 |
Price Performance
Historical ComparisonAbout CTO CTO Realty Growth Inc.
CTO Realty Growth Inc is a real estate investment trust company, that owns income properties in diversified markets in the United States. The company operates in four primary business segments: Income properties, management services, commercial loans and investments, and real estate operations. It derives maximum revenue from Income Properties.
About BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.